Literature DB >> 14740490

Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR.

Joeri L Aerts1, Monica I Gonzales, Suzanne L Topalian.   

Abstract

Real-time reverse transcription PCR (RT-PCR) is a sensitive and accurate method to monitor gene expression and is often used to profile the expression of putative tumor antigens in the context of immunotherapy. However, this technique consists of several steps, including cell processing, RNA extraction, RNA storage, assessment of RNA concentration, and cDNA synthesis prior to PCR. To compensate for potential variability introduced in this procedure, the expression of housekeeping genes is commonly assessed in parallel with the expression of the gene of interest. In this study, the expression of a variety of housekeeping genes in a panel of 26 different human tumor and embryonal cell lines was assessed using real-time RT-PCR. For some control genes, the variability in expression was significant between different cell lines, despite the equalization of quantities of input RNA. The greatest variability was found for GAPDH. The lowest variability was found for beta-glucuronidase (GUS) and 18S rRNA. While real-time RT-PCR is a powerful tool for gene expression analysis, these results suggest that the choice of control genes to normalize the expression of the gene of interest is critical to the interpretation of experimental results and should be tailored to the nature of the study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14740490     DOI: 10.2144/04361ST04

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  58 in total

1.  Measuring tissue-based biomarkers by immunochromatography coupled with reverse-phase lysate microarray.

Authors:  Martin J Romeo; John Wunderlich; Lien Ngo; Steven A Rosenberg; Seth M Steinberg; David M Berman
Journal:  Clin Cancer Res       Date:  2006-04-15       Impact factor: 12.531

2.  A multi-gene transcriptional profiling approach to the discovery of cell signature markers.

Authors:  Youichiro Wada; Dan Li; Anne Merley; Andrew Zukauskas; William C Aird; Harold F Dvorak; Shou-Ching Shih
Journal:  Cytotechnology       Date:  2010-10-23       Impact factor: 2.058

3.  Age, gender and litter-related variation in T-lymphocyte cytokine production in young pigs.

Authors:  Johanna de Groot; Leo Kruijt; Jan Willem Scholten; Wim J A Boersma; Willem G Buist; Bas Engel; Cornelis G van Reenen
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

4.  Successful RNA extraction from various human postmortem tissues.

Authors:  Marielle Heinrich; Katja Matt; Sabine Lutz-Bonengel; Ulrike Schmidt
Journal:  Int J Legal Med       Date:  2006-11-18       Impact factor: 2.686

5.  Monitoring and source tracking of tetracycline resistance genes in lagoons and groundwater adjacent to swine production facilities over a 3-year period.

Authors:  S Koike; I G Krapac; H D Oliver; A C Yannarell; J C Chee-Sanford; R I Aminov; R I Mackie
Journal:  Appl Environ Microbiol       Date:  2007-06-01       Impact factor: 4.792

6.  IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients.

Authors:  Mojgan Ahmadzadeh; Steven A Rosenberg
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

7.  Anti-inflammatory activity of Barleria lupulina: Identification of active compounds that activate the Nrf2 cell defense pathway, organize cortical actin, reduce stress fibers, and improve cell junctions in microvascular endothelial cells.

Authors:  Donald R Senger; Mien V Hoang; Ki Hyun Kim; Chunshun Li; Shugeng Cao
Journal:  J Ethnopharmacol       Date:  2016-09-20       Impact factor: 4.360

8.  Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.

Authors:  J M Gallego-Escuredo; J Gómez-Ambrosi; V Catalan; P Domingo; M Giralt; G Frühbeck; F Villarroya
Journal:  Int J Obes (Lond)       Date:  2014-05-12       Impact factor: 5.095

9.  Clinical relevance of survivin as a biomarker in neoplasms, especially in adult T-cell leukemias and acute leukemias.

Authors:  Kazuyuki Sugahara; Akiko Uemura; Hitomi Harasawa; Hiroshi Nagai; Yoichi Hirakata; Masao Tomonaga; Kenn Murata; Hiroshi Sohda; Toru Nakagoe; Sin-ichi Shibasaki; Yasuaki Yamada; Shimeru Kamihira
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

10.  Gene expression analysis of an EGFR indirectly related pathway identified PTEN and MMP9 as reliable diagnostic markers for human glial tumor specimens.

Authors:  Sergio Comincini; Mayra Paolillo; Giulia Barbieri; Silvia Palumbo; Elena Sbalchiero; Alberto Azzalin; Marika A Russo; Sergio Schinelli
Journal:  J Biomed Biotechnol       Date:  2009-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.